Although the story of artificial intelligence (AI) is dominated by tech giants south of the border, various Canadian shares win the grip in this very disturbing market.
In this article I have identified two of the best Canadian AI shares that you can buy in October 2025 to generate large returns. Let’s dive deeper.
Celestics
Valued on a market capitalization of $ 39.4 billion, Celestics (TSX: CLS) Stock has risen almost 400% in the last 12 months. Celestica offers extensive end-to-end supply chain solutions and production services to technology companies worldwide.
It designs, produces and assembles electronics and hardware platforms in two main segments: advanced technology solutions and connectivity and cloud solutions.
Celestica serves original manufacturers of equipment, cloud service providers, hyperscalers and companies in space travel, defense, industrial, health care technology, communication and company markets.
Celestica delivered exceptional results in the second quarter, powered by an explosive demand for network equipment from Hyperscale customers that build AI Data Center infrastructure. It reported a turnover of $ 2.9 billion, an increase of 21% after year, while the adjusted income grew by 54% to $ 1.39 per share in Q2.
The Connectivity and Cloud Solutions segment has experienced a revenue increase with 28%, powered by Hyperscaler orders for 400 g and 800G network switches.
The income of communication increased by 75% as several 800G programs in addition to the continuing force in 400 g demand demand. The management noted that 800 g of volumes of parity reached 400 g in the quarter and now expected that every large Hyperscaler -customer will implement 800G switches.
Growing grant
In 2025, Celestica predicts sales to rise by 20% to $ 11.6 billion, with adapted profit growth predicted by 42%. It also expects the free cash flow to increase to $ 400 million in 2025, an increase of $ 261.4 million in 2024.
Celestica successfully raised his first Tomahawk 6 system within a few days after receiving silicon samples in June, so that the company was launched at the end of 2026 for the launch of 1.6-terabyte switch programs.
Analysts predict that Celestica’s turnover will increase from $ 9.6 billion in 2024 to $ 16 billion in 2027. During this period it is predicted that the adjusted profit will expand from $ 3.88 per share to $ 8.11 per share. If the technical shares are priced at 35 times ahead of income, this can win 16% in the coming 18 months.
Good health
Valued on a market capitalization of $ 1.4 billion, Good health (TSX: Well) is a healthcare company. The Canadian shares have returned more than 3,300% to shareholders since the first public offer in 2016. However, it also trades 44% under all time, so you can buy the dip.
In the second quarter of 2025, Well Health reported a record sale of $ 356.7 million, an increase of 57% year after year. For comparison, adapted EBITDA (income before interest, tax, depreciation and amortization) more than tripled to $ 50 million.
Well now 222 clinics with more than 1,000 doctors who serve more than a million patient visits for the first time. The company reached 40% revenue growth and 76% EBITDA growth in Canada, while retaining a strong organic growth rate of 25%.
The management showed an impressive capital tuting discipline, because the 31 clinic groups achieved $ 280 million with an average several of 9.4 times Ebitda and then improved operations to push the implicit super to only 4.7 times through operational improvements.
Well accelerates its Canadian expansion time line and at $ 100 million in adapted EBITDA instead of the end of the year. Analysts predict the turnover of $ 919.7 million in 2024 to $ 1.8 billion in 2029.
During this period, the free cash flow is expected to rise to $ 177.5 million, compared to an outflow of $ 6.7 million. If the TSX shares are priced at 20 times ahead FCF, it can rise 160% within the next four years.
#Canadian #companies #invest